Translated title of the contribution | : Use of statins, anticoagulants, antiaggregants and antiarrhythmic drugs in patients with COVID-19. The agreed experts' position of Russian society of cardiology, Eurasian Association of therapists, National Society on Atherothrombosis, Societies of Experts in urgent cardiology, Eurasian arrhythmology association |
---|
Shlyakhto, Y. V., Arutyunov, G. P., Belenkov, Y. N., Tarlovskaya, E. I., Konradi, A. O., Panchenko, E. P., Yavelov, I. S., Tereshchenko, S. N.,
Ardashev, A. V., Arutyunov, A. G., Grigorieva, N. Y., Dzhunusbekova, G. A., Drapkina, O. M., Koziolova, N. A., Komarov, A. L., Kropacheva, E. S., Malchikova, S. V., Mitkovskaya, N. P., Orlova, Y. A. & Petrova, M. M.
& 11 others,
Rebrov, A. P., Sisakian, H., Skibitsky, V. V., Sugraliyev, A. B., Fomin, I. V., Chesnikova, A. I., Shaposhnik, I. I., Zhelyakov, E. G., Kanorskii, S. G., Kolotsey, L. V. & Snezhitskiy, V. A.,
2020,
In: Kardiologiya. 60,
6,
p. 4-14 11 p.Research output: Contribution to journal › Article › peer-review